SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-19-000114
Filing Date
2019-02-14
Accepted
2019-02-14 10:46:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 kezar13ga1.htm SC 13G/A 49897
  Complete submission text file 0000935836-19-000114.txt   51376
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-448-6534
EcoR1 Capital, LLC (Filed by) CIK: 0001587114 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Subject) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90539 | Film No.: 19602407
SIC: 2834 Pharmaceutical Preparations